ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $232.82 +0.56%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $453.1 million versus the consensus estimate of $436.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
